Skip To Main Content
Allison Vanasse on Muck Rack

Allison Vanasse

As seen in: Nature, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Allison Vanasse’s profile

Articles by Allison Vanasse

Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial

|
By MacLean Sellars, Jessica Frank, Bohoon Shim, Allison Vanasse, Ruolin Liu, Cleo Forman, Chloe R. Tu, Su-Chun Cheng, Catherine Song, Kan Xiong, Haley E. Sax, Vipheaviny Chea, Wesley Lu, Micah Rickles-Young, Amit Sud, Martin Hayes, Oriol Olivé, Haley Greenslade, Carrie L. Cibulskis, Nir Hacohen, Edward F. Fritsch, Shuqiang Li, Kenneth J. Livak, Nabihah Tayob, Elizabeth Stover, Carolyn Krasner, Rebecca Porter, Ursula Matulonis, Gad Getz, Giacomo Oliveira, Patrick A. Ott, Jeremy Simon, Viktor A. Adalsteinsson, Derin B. Keskin, Panagiotis A. Konstantinopoulos, Catherine J. Wu, Kyohei K. Tabata, Antonia Kowelewski, Pia Jain, Andjela Crnjac, Savni Sarolkar
| Nature Verified
Abstract Personalized neoantigen-targeting cancer vaccines in the adjuvant setting are of increasing interest across malignancies. Here we report the results of a phase 1 clinical trial testing the feasibility and safety of personalized neoantigen-targeting cancer vaccines for high-grade epithelial ovarian cancer.
Open in Who Shared Issue with article?
Show More